Institutional & Market Access Partnerships

International Pharmaceutical Market Access for High-Growth Healthcare Markets

Hospital portfolios, differentiated formulations and consumer health partnerships across MENA, Selected African Markets and LATAM.

Request Portfolio Explore Our Portfolio

What we offer

Manufacturing Access

Direct access to established EU GMP-compliant manufacturing partners with export-ready product portfolios.

Distributor & Market Development

Structured market entry through established distributor networks and commercial execution.

Portfolio Strategy

Execution of tailored portfolios across OTC, hospital, oncology and specialty categories.

About PharmaLink

A Business Development Platform for International Pharmaceutical Growth

PharmaLink Iberia is an execution-driven pharmaceutical partnership platform supporting international commercialization, manufacturer-to-market coordination, go-to-market execution and structured market development across Europe, MENA, selected African markets and LATAM.

EU Manufacturing Base

Reliable European manufacturing capabilities and quality standards.

Commercial Alignment

Support in matching products, markets and qualified local partners.

Long-Term Development

Partnerships designed for continuity, scalability and sustainable growth.

Headquarters

Madrid, Spain

A European hub for international pharmaceutical partnerships, commercial coordination and market development.

Manufacturing Network

Selected European Manufacturing Capabilities

PharmaLink works with selected European pharmaceutical manufacturers operating under high GMP standards and prepared for international commercial development.

Representative Partner

Farmalider illustrates the type of European manufacturing partner PharmaLink works with: strong pharmaceutical capabilities, broad therapeutic coverage and export readiness for international distribution.

EU GMP & Pharmaceutical Quality Frameworks

Manufacturing under EU GMP standards and alignment with EU pharmaceutical quality and compliance frameworks for international markets.

Advanced R&D

Continuous innovation in pharmaceutical formulation.

Broad Portfolio

OTC, dental, hospital, cough & cold and specialty products.

Export Ready

Optimized supply chain for international distribution.

Hospital & Specialty Network

Additional European manufacturing collaborations across oncology, injectables, biosimilars and specialty hospital products.

Oncology & hospital injectables
Medical devices & consumables
Institutional healthcare supply partnerships

Execution Model

From Product to Market Execution

PharmaLink enables structured market entry through regulatory readiness, commercial execution and end-to-end delivery.

Marketing Authorizations (MA)

Access to products supported by European marketing authorizations through our manufacturing partner network.

CPP-Based Export Strategy

Structured export models based on Certificates of Pharmaceutical Product (CPP).

Regulatory Documentation

Coordination of regulatory documentation with manufacturing and local partners according to market-specific requirements.

Pricing & Commercial Structuring

Flexible pricing models and commercial structures adapted to each market.

End-to-End Execution

Coordination across manufacturers, authorised supply partners and local distributors to support reliable international commercial execution.

Market Entry Strategy

Structured entry into complex markets through local partnerships and execution models.

We don't just advise. We help execute.

PharmaLink provides direct access to pharmaceutical products, market access pathways and coordinated execution from manufacturer to local market partner.

Representative Partner Manufacturing Strength

Proven Scale Across Global Markets

Through selected European manufacturing partnerships, PharmaLink provides access to strong industrial capabilities and international market reach.

58+

Countries

335+

Registrations

Patent Families

Selected indicators from our European manufacturing partner network. These figures do not represent regulatory holdings or registrations owned by PharmaLink Iberia.

Institutional & Specialty Portfolios

Specialty Healthcare & Market Access Capabilities

Institutional healthcare portfolios, specialty biosimilars, differentiated formulations and scalable pharmaceutical partnerships across high-growth international markets.

OTC

OTC & Consumer Health

Differentiated Pain & Fever formulations, including Paracetamol, Ibuprofen, Ibuprofen Arginine and Dexketoprofen, in oral sticks, sachets, oral suspensions and selected topical presentations.

Beyond Conventional Generics

Differentiated pharmaceutical formats designed to create stronger consumer propositions and new opportunities within established therapeutic categories.

Typical formats

Oral Sticks Sachets Oral Suspensions Selected Topical Presentations Effervescents Orodispersible (ODT) Conventional Oral Dosage Forms

Dental

Dental Care

European-manufactured dental anesthetics for professional use, including Articaine + Epinephrine, Lidocaine + Epinephrine and Mepivacaine 30 mg/mL, as well as chlorhexidine-based oral antiseptics for pharmacy and institutional channels.

Typical formats

Dental Anesthetic Cartridges Mouthwash & Oral Gels

Hospital

Hospital Medicines

Injectables and institutional therapeutic products for hospital channels.

Typical formats

Vials Ampoules Pre-filled syringes Lyophilized

Respiratory

Cough & Cold

Selected Cough & Cold formulations combining established active ingredients with differentiated and convenient dosage formats.

Representative products

Cloperastine Fendizoate · Dextromethorphan HBr · Selected All-in-One Cold Combinations · Selected Ibuprofen Decongestant Combinations

Typical formats

Oral Solution Sticks Oral Suspension Sticks Sachets Lozenges Bottles

Product availability and specific formulations are subject to territory and partner confirmation.

Oncology

Oncology & Hospital Therapies

Institutional oncology therapies, injectable treatments and hospital-focused pharmaceutical solutions.

Representative presentations

Vials Lyophilized Injectables Infusion

Biosimilars

Biosimilars & Specialty Care

Biosimilar products and specialty therapies aligned with regulated market access pathways.

Wellness

Consumer Health & Wellness Platforms

Consumer health platforms for pharmacy channels, available through licensing and supply agreements with our manufacturing partner. Each platform covers one health area and can grow with new products and line extensions.

Microbiota Innovation Platform

Microbiota-based formulations across six health areas — immune, digestive, skin, women's, oral and metabolic — including a single-serve functional beverage format.

Women's Health Ranges

Three dedicated ranges covering everyday intimate care, fertility, pregnancy and postpartum nutrition, and menopause.

Paediatric Care

Age-adapted topical care and supplements for infants and children: soothing roll-ons for bumps and bites, balsamic ointment and patches for respiratory comfort, melatonin drops and a baby skincare line (body lotion, massage oil, nappy cream, gel-shampoo). Minimum age depends on the product, from 6 months.

Dermatology & Skin Care

Topical portfolio built on two proprietary technologies: a crackling gel spray (50–150 mL) for tired legs, after-sun and post-exercise care, and a patent-protected active ingredient used in anti-stretch-mark and firming creams. An atopic skin cream is in development.

Eye Care

Nutritional and topical eye care: dual-format capsules (hard + soft) for macular, retinal and ocular-surface support, with lutein, zeaxanthin, DHA/EPA and vitamins, plus a tea tree eyelid cleansing solution and comfort eye wipes.

Gummy Delivery Technology

A customisable gummy format (actives, dose, flavour and shape) used for multivitamin, iron, immune and sleep supplements, from 3 years.

Representative presentations

Gummies Capsules Oral Sticks Sachets Effervescents Oral Strips Drops Roll-ons Patches Crackling Gel Spray Eye Wipes Creams & Intimate Care

Representative portfolio, including products in development. Classification (food supplement, medical device, cosmetic or medicine), age range and availability depend on each product and market.

Global Markets

International Market Focus

PharmaLink prioritizes international markets with growing demand for trusted European pharmaceutical products.

Interconnected footprint

Madrid as a hub for international partner development

MENA

Iraq
UAE
Kuwait
Saudi Arabia
Jordan
Lebanon

Selected African Markets

Egypt
South Africa
Côte d’Ivoire
Guinea-Bisáu

Latin America

Mexico
Argentina

Why PharmaLink

A Clear Value Proposition

European manufacturing credibility combined with commercial alignment in international markets.

Manufacturing Access

Trusted access to selected European pharmaceutical manufacturing partners.

Qualified Partner Alignment

Connection with qualified local partners and healthcare stakeholders.

Market Understanding

Practical understanding of entry routes, positioning and opportunity development.

Flexible Execution

Collaboration models adapted to manufacturers, distributors and commercial goals.

Partnership Model

How We Work

We act as a strategic bridge between manufacturers and international partners, facilitating efficient and coordinated market access.

Identify

Assess products, market priorities and commercial fit.

Align

Connect manufacturers with relevant distributors and local stakeholders.

Develop

Support commercial follow-up, execution and long-term growth.

Get In Touch

Let’s Build Something Together

Whether you are a pharmaceutical manufacturer seeking international expansion or a distributor looking for quality European products, we would love to hear from you.

Office

PharmaLink Iberia S.L., Madrid, Spain

info@pharmalinkiberia.com